Renalytix AI And AstraZeneca Collaborate To Improve Chronic Kidney Disease Outcomes

 
• By Marion Webb

The companies will launch "precision medicine strategies" for chronic disease that use Renalytix' AI-enabled IVDs.

Human Body Organs (Kidneys with Urinary Bladder)

More from Deals

More from Business